Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation - PubMed (original) (raw)
Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation
Irene Paradisi et al. J Hum Genet. 2008.
Erratum in
- J Hum Genet. 2008;53(4):376
- Erratum to: Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.
Paradisi I, Hernández A, Arias S. Paradisi I, et al. J Hum Genet. 2008 Apr;53(4):376. doi: 10.1007/s10038-008-0256-4. J Hum Genet. 2008. PMID: 32041380
Abstract
The aggregation of patients with Huntington's disease (HD) around Lake Maracaibo, Zulia State, Venezuela, is widely recognized, but the epidemiology of HD in the whole country is relatively unstudied. We have examined 279 individuals from 60 unrelated affected families residing in various areas of Venezuela for the presence of CAG repeats and other features associated with HD. The number of expanded repeats in 139 carriers varied from 35 to 112. Based on our examination of 71 symptomatic individuals, we developed a log-transformed regression equation, y= -0.0238x + 2.6616, to enable the prediction of age of onset in asymptomatic carriers. Intragenic haplotypes were constructed with two VNTRs (variable number of tandem repeats) and two SNPs (single nucleotide polymorphisms) in the promoter region as well as CCG repeat and Delta2642 polymorphisms to assess kinship between families. In 43 of 45 tested families, the haplotype on the mutated chromosome was 1;G;C;7;(A). The other haplotypes observed, 1;G;C;7;(B) and 4;G;C;7;(A), were of Peruvian and French origins, respectively. The geographic source of the first affected ancestor was assessed in 54 families from 15 different states. Residents of the states of Miranda, Lara and Táchira, excluding those of Zulia, had a mutated allele prevalence five- to ninefold higher than that of other areas. A low (approx. 1/200,000) prevalence, a wide-spread distribution with aggregation in some states and a likely remote European Caucasoid origin are defining epidemiologic features of HD in Venezuela.
Similar articles
- Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
Agostinho Lde A, Rocha CF, Medina-Acosta E, Barboza HN, da Silva AF, Pereira SP, da Silva Idos S, Paradela ER, Figueiredo AL, Nogueira Ede M, Alvarenga RM, Hernan Cabello P, dos Santos SR, Paiva CL. Agostinho Lde A, et al. J Hum Genet. 2012 Dec;57(12):796-803. doi: 10.1038/jhg.2012.120. Epub 2012 Oct 11. J Hum Genet. 2012. PMID: 23051704 - Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India.
Pramanik S, Basu P, Gangopadhaya PK, Sinha KK, Jha DK, Sinha S, Das SK, Maity BK, Mukherjee SC, Roychoudhuri S, Majumder PP, Bhattacharyya NP. Pramanik S, et al. Eur J Hum Genet. 2000 Sep;8(9):678-82. doi: 10.1038/sj.ejhg.5200515. Eur J Hum Genet. 2000. PMID: 10980573 - Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
Masuda N, Goto J, Murayama N, Watanabe M, Kondo I, Kanazawa I. Masuda N, et al. J Med Genet. 1995 Sep;32(9):701-5. doi: 10.1136/jmg.32.9.701. J Med Genet. 1995. PMID: 8544189 Free PMC article. - Genetic aspects of Huntington's disease in Latin America. A systematic review.
Castilhos RM, Augustin MC, Santos JA, Perandones C, Saraiva-Pereira ML, Jardim LB; Rede Neurogenética. Castilhos RM, et al. Clin Genet. 2016 Mar;89(3):295-303. doi: 10.1111/cge.12641. Epub 2015 Aug 13. Clin Genet. 2016. PMID: 26178794 Review. - Epidemiology of Huntington disease.
Kay C, Hayden MR, Leavitt BR. Kay C, et al. Handb Clin Neurol. 2017;144:31-46. doi: 10.1016/B978-0-12-801893-4.00003-1. Handb Clin Neurol. 2017. PMID: 28947124 Review.
Cited by
- Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.
Alexandrov AI, Serpionov GV, Kushnirov VV, Ter-Avanesyan MD. Alexandrov AI, et al. Prion. 2016 May 3;10(3):221-7. doi: 10.1080/19336896.2016.1176659. Prion. 2016. PMID: 27220690 Free PMC article. - The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era.
Kounidas G, Cruickshank H, Kastora S, Sihlabela S, Miedzybrodzka Z. Kounidas G, et al. J Neurol. 2021 Nov;268(11):4170-4177. doi: 10.1007/s00415-021-10505-w. Epub 2021 Apr 15. J Neurol. 2021. PMID: 33856548 Free PMC article. - Minimal prevalence of Huntington's disease in the South of Brazil and instability of the expanded CAG tract during intergenerational transmissions.
Castilhos RM, Santos JAD, Augustin MC, Pedroso JL, Barsottini O, Saba R, Ferraz HB, Godeiro Junior C, Vargas FR, Salarini DZ, Furtado GV, Polese-Bonatto M, Rodrigues LP, Sena LS, Saraiva-Pereira ML, Jardim LB; RedeNeurogenética. Castilhos RM, et al. Genet Mol Biol. 2019 Apr-Jun;42(2):329-336. doi: 10.1590/1678-4685-GMB-2018-0032. Epub 2019 Jun 27. Genet Mol Biol. 2019. PMID: 31259362 Free PMC article. - Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 Patients.
Vishnevetsky A, Cornejo-Olivas M, Sarapura-Castro E, Inca-Martinez M, Rabinowitz D, Milla-Neyra K, Mazzetti P, Bird T. Vishnevetsky A, et al. Mov Disord Clin Pract. 2022 Dec 2;10(2):238-247. doi: 10.1002/mdc3.13625. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825038 Free PMC article. - Increased 10-Year Prevalence of Huntington's Disease in South Korea: An Analysis of Medical Expenditure Through the National Healthcare System.
Lee CY, Ro JS, Jung H, Kim M, Jeon B, Lee JY. Lee CY, et al. J Clin Neurol. 2023 Mar;19(2):147-155. doi: 10.3988/jcn.2022.0212. Epub 2023 Jan 17. J Clin Neurol. 2023. PMID: 36700478 Free PMC article.
References
- Ann Neurol. 1997 May;41(5):689-92 - PubMed
- Arq Neuropsiquiatr. 2000 Dec;58(4):977-85 - PubMed
- Invest Clin. 1991;32(3):107-8 - PubMed
- Mov Disord. 1990;5(2):93-9 - PubMed
- Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3872-6 - PubMed
MeSH terms
Substances
LinkOut - more resources
Medical